Hatfield, United Kingdom

David Jonathan McNair

This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Jonathan McNair. Retrieved from https://idiyas.com/inventor/david-jonathan-mcnair

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Jonathan McNair: Innovator in Pharmaceutical Science

Introduction

David Jonathan McNair is a notable inventor based in Hatfield, GB. He has made significant contributions to the field of pharmaceutical science, particularly in the development of quinolones used as MRS inhibitors and bactericides. His work has implications for improving healthcare and combating bacterial infections.

Latest Patents

David holds a patent for "Quinolones used as MRS inhibitors and bactericides." This innovation showcases his commitment to advancing medical treatments and addressing critical health challenges. He has been awarded 1 patent for his contributions in this area.

Career Highlights

David is currently employed at SmithKline Beecham Corporation, where he continues to work on innovative solutions in the pharmaceutical industry. His role at the company allows him to collaborate with other experts and contribute to groundbreaking research.

Collaborations

Throughout his career, David has worked alongside talented colleagues, including John Michael Berge and Pamela Brown. These collaborations have enriched his work and fostered a creative environment for innovation.

Conclusion

David Jonathan McNair is a distinguished inventor whose work in pharmaceutical science has made a significant impact. His dedication to innovation and collaboration continues to drive advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…